description
Powered by Eupheria Biotech
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
TACGGGTCCTGCTTAGGAGAAAAGAAAAACGTCTTACAGCCAGTGTCTAAACTCCAAACAACGGAATGTATCAATGAGACCTTGTATATGGATACACGTGCATTTAAAACCGCCCTGCCGGCTTGTAGAGCTTTTGCCGTTCTCCAGCGCTTTACAGGGGTTATCGCACTTAAGCCTCGGAACAACTTTACCAGTGATTCTACCAGAAAGGAATGAAGAACAGAACCTTCAGGAATTGAGTCACAATGCAGACAAATATCAAATGGGAGATTGTTGCAAGGAAGAGATTGATGATAGTATTTTCTACTAGCCATTGGGAAGATAAAAGGAGACAGAAGATTGAAGCCTTTGCCAGCCATTCTTTCCCTTTTTGCTTCCAAACTCCTCAACTGGGAACCTTCATATGTGCAGTATTTATATTGGATCATACTGGTGATTATAAAAGTTCCTAGGAGGCTAGAAGAGCCAACCAACAGAGAAGGGAA
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Quality Level
Gene Information
human ... DLEU1(10301)
General description
MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
法规信息
新产品
此项目有
Hangbo Li et al.
OncoTargets and therapy, 13, 2037-2045 (2020-03-28)
Cisplatin (DDP) resistance has become an obstacle to chemotherapy for nasopharyngeal carcinoma (NPC) patients. Recent evidences indicate that long noncoding RNAs (lncRNAs) are involved in tumorigenesis and chemoresistance. However, the potential role of lncRNAs in NPC progression remains largely unknown.
Wei Liu et al.
Cell biochemistry and function, 38(7), 886-894 (2020-03-21)
According to statistics, abnormal regulation of lncRNAs pivotally influences multiple malignant tumours. DLEU2, as one of these lncRNAs, is detected to be related to growth and development of tumours. The molecular mechanisms of DLEU2 in osteosarcoma, however, are still unknown.
Xiaoyun He et al.
Journal of Cancer, 12(2), 428-437 (2021-01-05)
Emerging evidence indicates that long noncoding RNAs (lncRNAs) are closely associated with colorectal cancer (CRC) tumorigenesis. One example is lncRNA Deleted in Lymphocytic Leukemia 2 (DLEU2). However, how DLEU2 contributes to CRC is still poorly understood. This study sought to
Song Gao et al.
Journal of cellular physiology, 234(5), 6746-6757 (2018-11-02)
Recent evidence has highlighted that long noncoding RNAs (lncRNA) are associated with many diseases, particularly cancer. However, current understanding of the lncRNA deleted in lymphocytic leukemia 1 (DLEU1) in pancreatic ductal adenocarcinoma (PDAC) remains limited. Our studies indicated that the
Li Feng et al.
OncoTargets and therapy, 12, 5405-5414 (2019-07-31)
Long noncoding RNA (lncRNA) deleted in lymphocytic leukemia 1 (DLEU1) was reported to be involved in the development and progression of multiple cancers. However, the accurate expression pattern, biological function and potential molecular mechanism of DLEU1 in glioma are not
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持